Skip to main content
. 2022 Jan 6;194(1):215–231. doi: 10.1007/s12010-021-03791-7

Fig. 4.

Fig. 4

2D Interaction of ligands with VEGFR-2. (1) Oleanolic acid, (2) Panaxadiol, (3) Panaxatriol, (4) Ursolic acid, (5) Withaferin A, (6) Hecogenin, (7) Dovitinib, (8) Gefitinib